Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT02349412What this trial is testingEarly Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversWho this might be right forLiver CancerAnxiety DisorderDepression+7 more Alliance for Clinical Trials in Oncology 405
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)Active Not RecruitingNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18
Not applicableEnded earlyNCT00896467What this trial is testingPsychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyWho this might be right forAnal CancerAnxiety DisorderBreast Cancer+9 more Centre Oscar Lambret 200
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Early research (Phase 1)UnknownNCT04460456What this trial is testingSBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsWho this might be right forHER2 Positive Solid Tumors Silverback Therapeutics 58
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT07023731What this trial is testingEvaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationWho this might be right forKRAS G12D MutationAdvanced Solid Cancer Arvinas Inc. 159
Testing effectiveness (Phase 2)Ended earlyNCT05012397What this trial is testingMilademetan in Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more Rain Oncology Inc 40
Testing effectiveness (Phase 2)UnknownNCT05527821What this trial is testingStudy of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid TumorsWho this might be right forUnresectable Advanced Solid TumorsBiliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Study completedNCT05253053What this trial is testingTo Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more TransThera Sciences (Nanjing), Inc. 84
Early research (Phase 1)Looking for participantsNCT07334119What this trial is testingSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsWho this might be right forHER2-Expressing Solid Tumors Myeloid Therapeutics 60
Early research (Phase 1)Not Yet RecruitingNCT07036185What this trial is testingA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsWho this might be right forGastric/Gastroesophageal Junction CancerBreast CancerColorectal Cancer+3 more Shanghai Bao Pharmaceuticals Co., Ltd. 66
Early research (Phase 1)Looking for participantsNCT06043466What this trial is testingA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsWho this might be right forColorectal CancerEsophagus CancerGastric Cancer+4 more Chongqing Precision Biotech Co., Ltd 30
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT02443324What this trial is testingRamucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerWho this might be right forGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionNon-small Cell Lung Cancer+2 more Eli Lilly and Company 175
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Not applicableStudy completedNCT00836992What this trial is testingQuality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+8 more Mayo Clinic 144